Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: J Clin Pharmacol. 2015 Feb 4;55(5):556–562. doi: 10.1002/jcph.449

Table 3.

Bias and precision of abiraterone oral clearance at the population level and individual level, between-individual variability, and between-occasion variability

Between-occasion variability Number of patients in trial Oral Clearance – Population level Oral Clearance – Individual level Between-individual variability Between-occasion variability Food effect
Bias Precision Bias Precision Bias Precision Bias Precision Bias Precision
10% 20 −32.3% 37.1% 1.5% 14.5% −44% 45.6% −30% 40.7% 2.65% 9.95%
50 −36.6% 37.8% 1.3% 14.6% −43.6% 44.5% −25.8% 30.8% 4.42% 7.42%
70 −36.8% 37.8% 1.4% 14.9% −43.3% 43.5% −15.3% 23.3% 3.84% 6.81%
25% 20 −31.7% 36.6% 3.3% 19.6% −45.1% 45.9% −5.85% 18.8% 2.36% 11.8%
50 −36.3% 37.6% 1.2% 18.9% −42.4% 42.8% −5.51% 14.6% 4.16% 8%
70 −36.9% 37.9% 3.2% 19.9% −43 % 43% −3.08% 14.8% 3.61% 7.22%
40% 20 −31% 36.2% 1.4% 19.7% −44.9% 46.1% −1.34% 17.4% 2.01% 14.4%
50 −35.7% 37.1% 1.6% 19.9% −42.1% 42.8% −1.44% 13.4% 2.52% 11.9%
70 −37% 38.1% 4.4% 19.6% −42.6% 43% −1.11% 11.6% 2.64% 8.6%